[Clinical and morphological parallels in mitral valve disorders in infants with atrioventricular defect]

Insights

Myxomatous degeneration in pediatric mitral valves, linked to atrioventricular defects, indicates poor surgical outcomes. This tissue change is a key indicator for future mitral valve regurgitation.

Area of Science:

  • Cardiovascular Pathology
  • Pediatric Cardiology
  • Surgical Pathology

Background:

  • Atrioventricular defects (AVDs) are congenital heart conditions requiring surgical intervention.
  • Residual mitral valve regurgitation (MVR) can occur post-correction, necessitating further evaluation.
  • Mitral valve tissue characteristics in pediatric AVDs are not fully understood.

Purpose of the Study:

  • To investigate the histological and ultrastructural features of mitral valve tissue in children with complete and partial atrioventricular defects.
  • To determine the correlation between myxomatous degeneration and the severity of mitral valve regurgitation.
  • To assess the prognostic value of myxomatous degeneration in patients undergoing mitral valve surgery for AVDs.

Main Methods:

  • Histological examination of mitral valve tissue samples from 19 pediatric patients with AVDs.
  • Ultrastructural analysis to classify cell types within the mitral valve tissue.
  • Immunohistochemistry to determine cell phenotypes, including fibroblastic, endothelial, and smooth muscle differentiation.

Main Results:

  • Myxomatous degeneration was identified in 32% of patients, occupying over 50% of the mitral valve surface.
  • Areas of myxomatous degeneration showed dispersed star-shaped cells, disturbed architecture, acid mucopolysaccharide deposition, and increased matrix metalloproteinase 13.
  • The extent of myxomatous degeneration correlated with the grade of mitral valve regurgitation and was associated with a higher rate of suture dehiscence post-surgery, indicating a poor prognosis.

Conclusions:

  • Myxomatous degeneration is a significant pathological finding in pediatric mitral valves associated with atrioventricular defects.
  • Wider areas of myxomatous degeneration predict poorer surgical outcomes, including increased risk of suture dehiscence and residual mitral valve regurgitation.
  • The cellular composition includes fibroblasts, myofibroblasts, and isolated histiocytes, with varying degrees of fibroblastic, endothelial, and smooth muscle differentiation.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...